A5041599101- Vaccine Coverage and Hesitancy
- Pediatric Pain Management Techniques
- Influenza Virus Research Studies
- Immune responses and vaccinations
- Intramuscular injections and effects
- Infant Health and Development
- Heparin-Induced Thrombocytopenia and Thrombosis
- Cervical Cancer and HPV Research
- COVID-19 Impact on Reproduction
- Thermal Regulation in Medicine
- Hepatitis B Virus Studies
- Atrial Fibrillation Management and Outcomes
- Pharmaceutical studies and practices
- Immunodeficiency and Autoimmune Disorders
- Ethics and Legal Issues in Pediatric Healthcare
- Hepatitis Viruses Studies and Epidemiology
- Cystic Fibrosis Research Advances
- Restraint-Related Deaths
- Bacterial Infections and Vaccines
- Family and Patient Care in Intensive Care Units
- Antiplatelet Therapy and Cardiovascular Diseases
- Healthcare cost, quality, practices
- Kawasaki Disease and Coronary Complications
- Anesthesia and Sedative Agents
- PI3K/AKT/mTOR signaling in cancer
Royal Children's Hospital
2010-2024
Murdoch Children's Research Institute
2008-2024
The University of Melbourne
2021
Boston Children's Hospital
2015
University of Rome Tor Vergata
2013
University Hospital Lewisham
2011
Australian National University
2008
Direction Générale de la Météorologie
2004
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and its prevalence ∼1–2% of general population, but higher with increasing age in patients concomitant heart disease. The Cox-maze III procedure was a groundbreaking development remains surgical intervention highest cure rate, due to technical difficulty alternative techniques have been developed create lesions sets. field fast moving there are now multiple energy sources, potential lesion sets even guidelines...
BCG vaccination modulates immune responses to unrelated pathogens. This off-target effect could reduce the impact of emerging As a readily available, inexpensive intervention that has well-established safety profile, is good candidate for protecting healthcare workers (HCWs) and other vulnerable groups against COVID-19.
To describe the outcomes of clinical evaluation, skin testing, and vaccine challenge in adolescent schoolgirls with suspected hypersensitivity to quadrivalent human papillomavirus introduced Australian schools 2007.Retrospective cohort study.Two tertiary paediatric allergy centres Victoria South Australia, Australia.35 aged 12 18.9 years reactions vaccine.Clinical review prick intradermal testing subsequent vaccine.35 were notified specialised immunisation services 2007, after more than 380...
The study aims to identify pain management practices used during scheduled childhood immunisation.A survey of members the Australian Nurses Federation (Victorian Branch) Immunisation Special Interest Group. Questions included frequency use reduction strategies immunisations for infants, toddlers and children, injection techniques existence an articulated policy.The was emailed 274 Group with registered email addresses, 125 (46%) completed survey. Nineteen respondents (15.2%) stated their...
Objective: To quantify and characterise the reports of syncope seizures following quadrivalent (4v) human papillomavirus (HPV) vaccination. Design setting: Retrospective case series notifications to SAEFVIC (Surveillance Adverse Events Following Vaccination In Community), May 2007 – April 2009. Main outcome measures: Incidence seizure 4vHPV vaccination; clinical outcomes. Results: 97/1653 met study criteria: afebrile (3), syncopal (31) alone (63). Median age at vaccination was 15 years...
The Face, Legs, Activity, Cry, Consolability (FLACC) scale is a five-item tool that was developed to assess postoperative pain in young children. frequently used as an outcome measure studies investigating acute procedural children; however, there are limited published psychometric data this context.To establish inter-rater and intrarater agreement of the FLACC toddlers during immunization.Participants comprised convenience sample recruited from immunization drop-in service, who were part...
Vaccines can have beneficial off-target (heterologous) effects that alter immune responses to, and protect against, unrelated infections. The heterologous of COVID-19 vaccines not been investigated in children.To investigate specific immunological BNT162b2 vaccination children.A whole blood stimulation assay was used to vitro cytokine stimulants (killed pathogens, Toll-like receptor ligands) SARS-CoV-2 antigens. Samples from 29 children, aged 5-11 years, before 28 days after a second were...
Abstract Attaining high immunisation coverage rates for children with medical conditions is vital. The Royal Children's Hospital (RCH) Immunisation Service has the opportunity to check each inpatient's status and provide opportunistic vaccines and/or bring Australian Childhood Register (ACIR) up‐to‐date. This paper highlights that during admission, one quarter of were not up‐to‐date routine scheduled immunisations 42% those inpatients due or overdue vaccinated. model establishing checking...
Background: The Human Papillomavirus (HPV) vaccine is offered in Australia to all males and females at 12 13 years. In 2015 the national HPV coverage was 77.4% for 66.4% males. There no Australian data subgroup of adolescents with disabilities.Method: We reviewed status 14 year-old who attended a developmental medicine clinic tertiary hospital Melbourne during 2014. Motor function intellectual impairment were also recorded.Results: Of 72 audit, only 39.5% 44.1% fully immunised against HPV....
Aim: The Australian Immunisation Handbook (ninth edition) recommends children with cystic fibrosis (CF) receive routine scheduled immunisations plus annual influenza vaccine and an additional pneumococcal at both 12 months 4–5 years. Adherence these recommendations is unknown. This study aimed to determine the immunisation status of CF attending Royal Children's Hospital (RCH), Melbourne. Methods: A retrospective audit aged 6 7 years (at 1 January 2008) was performed on RCH outpatient clinic...
Patients at increased risk of vaccine preventable diseases require additional vaccines that are not licensed for Nurse Immunisers to administer without a prescription. An Immunisation Practitioner (NP) the Royal Children's Hospital (RCH) Melbourne was introduced address deficiencies in current management these patients. NP endorsement requires successful completion Masters level study program, plus equivalent three years (5,000) hours full-time experience advanced clinical nursing. The...
Abstract International Health and Medical Services (IHMS) are contracted to provide health services, including catch‐up vaccination, for individuals in immigration detention. Our audit of vaccination asylum seeker children who spent time held detention demonstrates inadequate suboptimal vaccine delivery this setting, no evidence that IHMS recorded vaccines on the Australian Childhood Immunisation Register at time. We also found substantial shortfalls these after they were released from...
Aim Pain associated with immunisations can result in distress and/or anxiety for children and parents. We assessed the feasibility acceptability of two novel devices; Coolsense (cold) Buzzy (vibration ± cooling pads) versus standard care to minimise pain during immunisations. also evaluated compliance devices parent's perception effectiveness devices/standard minimising immunisation. Design Open label, pilot, randomised controlled trial (RCT). Methods Forty aged 3.5 6 years attending an...
We describe the clinical profile of children and outcomes influenza immunisation for patients in a paediatric intensive care unit (PICU).Over two seasons: 19/04/2018 to 07/08/2018 02/05/2019 10/10/2019, an nurse PICU coordinator met weekly identified receive vaccine. An inpatient list was screened eligible patients: greater than 6 months age, did not have imminent procedures (e.g. surgery) or were critically unwell, as determined by treating team, Patients excluded if they had undergone...
The aim was to establish whether suboptimal care or system failures in the delivery of contributed mortality patients admitted with a predicted low risk death our ICU.